ライフサイエンスコーパス: in the setting of

1 ived either a 6 h lipid or glycerol infusion in the setting of a concurrent hyperinsulinaemic-euglyca

2 buted to non-hepatitis C-infected recipients in the setting of a first and nonurgent transplantation.

3 oninvasive method for diagnosing renal flare in the setting of a known diagnosis of SVV.

4 suspicion for healthcare-associated LD, even in the setting of a long-term disinfection program.

5 %), less than 10 mm in size (73%), and arose in the setting of a main duct IPMN (96%).

6 Conclusion In the setting of a MDBCC, TMT yielded survival outcomes

7 rosclerotic plaque, whereas type 2 MIs occur in the setting of a mismatch between oxygen demand and s

8 The impact of antithymocyte globulin (ATG) in the setting of a myeloablative conditioning transplan

9 count for highly sensitive mechanical gating in the setting of a narrow, cation-selective pore.

10 g evidence to assess whether anticoagulation in the setting of a new bioprosthesis was associated wit

11 and class 2 test results are indeed possible in the setting of a nonmelanoma malignancy.

12 d that all major ICHs on enoxaparin occurred in the setting of a PANWARDS score >/=25, corresponding

13 -refractory tremor by CRST assessments, even in the setting of a placebo response.

14 f cancer and how it is diagnosed and treated in the setting of a severe lack of resources (physical a

15 mechanism, and management of VT that occurs in the setting of a structurally normal heart and the ro

16 st, VT or premature ventricular contractions in the setting of a structurally normal heart carries a

17 to ventricular tachycardia (VT) that occurs in the setting of a structurally normal heart, VT that o

18 contraindications to antiplatelet therapy or in the setting of a subarachnoid haemorrhage.

19 results suggest that low antigenic diversity in the setting of a unique inflammatory profile associat

20 omote medical students' emotional well-being in the setting of a US academic medical school, with an

21 f mIL-6 was able to improve plaque clearance in the setting of Abeta suppression.

22 urine model to enable study of immunobiology in the setting of ABOi transplantation.

23 h among patients with moderate-to-severe CKD in the setting of acceptable complication rates.

24 d major adverse cardiovascular events (MACE) in the setting of acute coronary syndrome.

25 However, its safety and long-term efficacy in the setting of acute dacryocystitis with lacrimal sac

26 investigate the fate of MDSCs after transfer in the setting of acute GVHD (aGVHD).

27 's possible contributions to pathophysiology in the setting of acute injuries.

28 cessing and enhances apoA-IV gene expression in the setting of acute steatosis.

29 x-based differences underlie arrhythmia risk in the setting of acute sympathetic nervous system disch

30 sleep and Abeta homeostasis may be connected in the setting of AD.

31 dyslipidemia and insulin resistance, occurs in the setting of adipose inflammation and operates in c

32 effacement, and to decreased podocyte number in the setting of Adriamycin (ADR)-induced nephropathy.

33 hospitalized patients with agitated delirium in the setting of advanced cancer, the addition of loraz

34 rsistent agitation in patients with delirium in the setting of advanced cancer.

35 esistance to endocrine therapies, especially in the setting of advanced disease, remains an impedimen

36 he first 'anti-arrhythmic' adaptive response in the setting of AF and appears to counteract the malad

37 Diagnosis of HFpEF in the setting of AF is challenging because the symptoms

38 for both stroke and atrial fibrillation, and in the setting of AF, type 2 diabetes is independently a

39 a for defining atrophy based on OCT findings in the setting of age-related macular degeneration (AMD)

40 el features of stress adaptation, especially in the setting of ageing.

41 portionately prone to these cardiac diseases in the setting of alcohol abuse.

42 ic vasculature as a novel therapeutic target in the setting of allo-HSCT.

43 In the setting of allogeneic nonmyeloablative HSC transp

44 itD status and correction of VitD deficiency in the setting of alloSCT are highly warranted.

45 the cellular and molecular events that occur in the setting of altered nutrient and energy exposures

46 Changes in Wnt signaling in the setting of altered TIEG1 expression and/or activi

47 system and criteria for OCT-defined atrophy in the setting of AMD has been proposed based on an inte

48 upport) registry who underwent VAD placement in the setting of AMI were included and compared with pa

49 ve effect, causing mitochondrial dysfunction in the setting of an abnormal kinesin "motor." These res

50 evious studies suggests that anticoagulation in the setting of an aortic bioprosthesis significantly

51 carcinoma or high-grade dysplasia) occurring in the setting of an MCN.

52 e role of IFN-gamma signaling in tumor cells in the setting of anti-CTLA-4 therapy remains unknown.

53 rmine the eyes most at risk of developing GA in the setting of anti-VEGF treatment.

54 c immune response, has not been well studied in the setting of AR.

55 nd virions in promoting recrudescent viremia in the setting of ART cessation is essential.

56 od pressure, blood glucose levels, and fever in the setting of arterial ischemic stroke.

57 ting a pathway for ameliorating eosinophilia in the setting of asthma and other eosinophil-associated

58 ential strategy for enhancing oral tolerance in the setting of autoimmune and inflammatory diseases.

59 se cholesterol transport could be beneficial in the setting of autoimmune disease.

60 We examined the role of neuroimaging in the setting of autoimmune encephalitides, comparing t

61 that is vulnerable to inflammation and edema in the setting of autoimmune thyroid disease.

62 Human gut bacterial taxa targeted by IgA in the setting of barrier dysfunction are capable of pro

63 apy response, we sought to characterize BCCs in the setting of BCNS.

64 ctive cohort studies have shown a high value in the setting of biochemical recurrence, with high dete

65 o determine the impact of targeted treatment in the setting of bladder cancer.

66 s benefit was identified using this approach in the setting of BM transplantation.

67 athetic nervous system discharge was applied in the settings of both inherited and acquired long-QT s

68 ly discovered NRAS isoform 2 is up-regulated in the setting of BRAF inhibitor resistance in melanoma,

69 performed CRISPR-Cas9 gene deletion screens in the setting of BRAF, MEK, EGFR, and ALK inhibition.

70 pproach for localizing neurological symptoms in the setting of brain lesions.

71 about the application of these technologies in the setting of breast reconstruction have arisen.

72 oidal reflectivity may warrant further study in the setting of BSCR.

73 ts affected by SAN dysfunction, particularly in the setting of Ca(2+) overload.

74 k during neuronal apoptosis and specifically in the setting of Ca(2+)- and seizure-mediated neuronal

75 1) and several variants previously described in the setting of cancer but that, to our knowledge, hav

76 titumor immune responses mediated by T cells in the setting of cancer vaccine therapy.

77 modeling of chromatin on a genome-wide scale in the setting of cardiac disease.

78 gulation of voltage-gated potassium currents in the setting of cardiac pathology and may provide a no

79 identified 76 474 patients who underwent PCI in the setting of cardiogenic shock at one of 1429 Natio

80 RNA content may affect vascular inflammation in the setting of cardiovascular disease.

81 rough rapamycin, a potent autophagy inducer, in the setting of CGD.

82 nses and have proven to be effective targets in the setting of chronic diseases where constitutive co

83 In the setting of chronic HCV alone, statin initiators h

84 y an abrupt improvement in glycaemic control in the setting of chronic hyperglycaemia.

85 onic for nephrogenic systemic fibrosis (NSF) in the setting of chronic renal disease with associated

86 ssisting radiologists in response assessment in the setting of clinical trials or routine practice.

87 -in the daily treatment of patients, as well in the setting of clinical trials, is an important chall

88 graft-versus-host disease (GVHD) that occurs in the setting of clinically relevant immune suppression

89 rst map of this evolving process in primates in the setting of clinically relevant immunomodulation.

90 ensitivity that preserve glucose homeostasis in the setting of cold exposure.

91 f purinergic receptor pathways, particularly in the setting of combination therapies, could become a

92 hich offer considerable potential especially in the setting of combination therapy.

93 apy and increase the rate of disease control in the setting of combined modality or more intensive th

94 in patients with hypertrophic cardiomyopathy in the setting of comprehensive and targeted panels.

95 hat can be associated with retinochoroiditis in the setting of congenital toxoplasmosis in human infa

96 In the setting of coronary artery disease, either transm

97 ting therapeutic mechanisms of drug efficacy in the setting of CPVT and then using these mechanisms t

98 predictions of drug mechanisms and efficacy in the setting of CPVT.

99 cus aureus is the leading cause of infection in the setting of critical illness and injury.

100 therapy that may be particularly beneficial in the setting of critical illness and injury.

101 rther research into neoadjuvant chemotherapy in the setting of CRS and HIPEC for PMs.

102 tance of rational antibiotic use, especially in the setting of culture-negative neonatal sepsis.

103 clinical significance of troponin elevation in the setting of decompensated HF with preserved ejecti

104 ainst severe RVD was higher than anticipated in the setting of delayed dosing.

105 In the setting of demyelination, these changes may be re

106 NAC accelerates healing of amputation stumps in the setting of diabetes and ischemia.

107 sms underlying poor amputation stump healing in the setting of diabetes are not understood.

108 giogenesis and may have therapeutic benefits in the setting of diabetes.

109 value of 1,5-AG for long-term complications in the setting of diabetes.

110 e pathogenesis of atherosclerosis, including in the setting of diabetes.

111 ysteine accelerates amputation stump healing in the setting of diabetes.

112 ntact in LRKO mice and increased as expected in the setting of diet-induced insulin resistance.

113 eir test characteristics have been described in the setting of differentiating IBD from irritable bow

114 occurs normally, especially with aging, and in the setting of disease, not only in myeloid cancers b

115 ative and HER2-overexpressing breast cancers in the setting of elevated circulating LDL-C, which may

116 lts suggest that alvimopan is cost-effective in the setting of enhanced recovery colorectal surgery p

117 a mediator of cancer-associated inflammation in the setting of epidermal carcinogenesis.

118 should be informed if biopsies are obtained in the setting of erosive esophagitis and if pathology f

119 esions is a unique phenomenon that can occur in the setting of eruptive nevi or epidermotropic melano

120 cidosis on the nuclear factor-kappaB pathway in the setting of Escherichia coli-induced lung injury a

121 m of neuronal inhibition that is amplifiable in the setting of excess electrical activity.

122 IAV but are likely to be infected indirectly in the setting of exposure in the presence of antibody t

123 Acute intra-arterial treatment (IAT) in the setting of extracranial and intracranial lesions

124 regulators in determining thrombosis balance in the setting of F5(L) and also suggest a role for Actr

125 ron emission tomographic study was performed in the setting of first-episode psychosis services in an

126 origin for pancreatic ductal adenocarcinoma in the setting of gain-of-function mutations in p53.

127 al cells, approximately 5% of all CRCs arise in the setting of germline mutations in genes involved i

128 n muscle mass and function was also observed in the setting of glucocorticoid addition, which is a st

129 tor of DC-mediated adaptive immune responses in the setting of HDM-induced eosinophilic airway inflam

130 In the setting of health-care clinics in DR Congo with a

131 risk of such direct electrical interactions in the setting of healthy adult myocardium was predicted

132 clinical studies have already been performed in the setting of hematological malignancies.

133 recommendation involved platelet transfusion in the setting of hematopoietic stem-cell transplantatio

134 odulates both hepatic steatosis and fibrosis in the setting of hepatic Mttp deletion, adding new insi

135 le when early stasis or reflux is a concern, in the setting of hepatocellular carcinoma with portal v

136 ed to define the optimal duration of therapy in the setting of HEV infection.

137 Our results indicate that in the setting of HF, potentiation of the CB chemoreflex

138 yocardial fibrosis, and improves LV function in the setting of HF.

139 y contribute to ventricular arrhythmogenesis in the settings of HF-associated remodeling.

140 s the available data for the treatment of AF in the setting of HFrEF, focuses on areas where more inv

141 ed by expression of CD16, which was elevated in the setting of high malaria transmission.

142 s to acceptable toxicity and disease control in the setting of high risk, heavily pretreated patients

143 exist on the superiority of these materials in the setting of high-risk wounds in patients.

144 bDeltasigH, delivered directly to the lungs, in the setting of HIV co-infection.

145 Causes of liver disease in the setting of HIV infection include viral hepatitis,

146 ic controls of bNAb induction and maturation in the setting of HIV infection, and point to key roles

147 contribute to the development of lung cancer in the setting of HIV infection.

148 contribute to the development of lung cancer in the setting of HIV infection.

149 odies (bnAbs) to date has only been observed in the setting of HIV-1 infection, and then only years a

150 of human neutrophils ex vivo and is produced in the setting of human infection.

151 ts modulate platelet production and activity in the setting of hypercholesterolemia, amenable to phar

152 on, leading to increased platelet activation in the setting of hypercholesterolemia.

153 ial thrombosis and atherosclerosis, but only in the setting of hypercholesterolemia.

154 The binding is reversible in the setting of hyperglycemia, resulting in fast relea

155 hyperreactivity and the prothrombotic state in the setting of hyperlipidemia by sensing a wide range

156 ibute to accelerated thrombosis specifically in the setting of hyperlipidemia.

157 contributes to accelerate thrombosis in mice in the settings of hyperlipidemia.

158 ncRNA, FOXD3-AS1, known as linc1623 in mice, in the setting of hyperoxia/reactive oxygen species (ROS

159 of FAP chemoprevention, with caution advised in the setting of IBD.

160 t a significant subset of ocular MZLs arises in the setting of IgG4-RD.

161 therapy in suspected autoimmune encephalitis in the setting of immune checkpoint inhibitor use.

162 red etiology for cutaneous SCC and other SCC in the setting of immunosuppression.

163 XBP1 can protect against polycystic disease in the setting of impaired biogenesis of PC1.

164 that WRCs may serve as a therapeutic target in the setting of impaired skeletal regeneration.

165 Unhealthy eating behaviors often develop in the setting of inadequate inhibitory control, a funct

166 maintain spatial working memory performance in the setting of increased difficulty.

167 ia (serum potassium concentration >5 mmol/L) in the setting of increased potassium intake.

168 In the setting of increased reliance on quality indicato

169 of portal flow modulation on graft outcomes in the setting of increasing use of smaller and left lob

170 In the setting of increasingly common measles outbreaks

171 Among HIV-infected pregnant women in the setting of indoor residual spraying of insecticid

172 te human T cell dependent antibody responses in the settings of infection, vaccination, or immune dys

173 nist in non-pathological conditions, whereas in the setting of inflammation, ANG2 functions as a Tie2

174 t excessive activation of coagulation occurs in the setting of inflammation.

175 an alternative noncatecholaminergic support in the setting of inflammatory cardiovascular dysfunctio

176 ctor-kappaB, a pivotal transcription factor, in the setting of injury, inflammation, and repair, but

177 de-differentiation and trans-differentiation in the setting of injury.

178 significant source of circulating RBP4, even in the setting of insulin resistance.

179 of accompanying drug ingestions, especially in the setting of intentional poisoning, fire-related to

180 risk of endothelial dysfunction, especially in the setting of intraocular surgery.

181 rkable improvement in disease manifestations in the setting of iron deficiency.

182 y exploring the metabolic changes that occur in the setting of ischemia-reperfusion.

183 reserves tissue survival and muscle function in the setting of ischemia.

184 lso regulates cytosolic RNA-sensing pathways in the setting of ischemic stress.

185 HBV reactivation of varying severity, even in the setting of isolated hepatitis B core antibody, wi

186 thropoietin production and ameliorate anemia in the setting of kidney fibrosis in mice.

187 ifferentially regulate LC mobility/migration in the setting of limited inflammation as compared with

188 This is particularly relevant in the setting of limiting dilution assay where cells ar

189 Acute injury in the setting of liver fibrosis is an interesting and s

190 egulates metabolic and immune response genes in the setting of low oxygen tension and inflammation.

191 Although these mechanisms were protective in the setting of low sugar and low salt intake in our p

192 h mortality (but not hospitalization for HF) in the setting of lower sodium.

193 ng vascular integrity by targeting pericytes in the setting of LPS-induced sepsis.

194 earance could exacerbate fibrogenic pathways in the setting of lung diseases characterized by epithel

195 These results demonstrate that, in the setting of lupus-like CD4 T cell-driven B cell hy

196 we show that depletion of regulatory T cells in the setting of lymphatic injury restores these critic

197 the possibility of recurrence of sarcoidosis in the setting of maintenance immunosuppression, the nee

198 broblast crosstalk and profibrotic signaling in the setting of maladaptive kidney repair.

199 eration, and cytokine expression are reduced in the setting of malnutrition and increased in obesity,

200 evidence for a pathogenic role of IFN-gamma in the setting of MAS.

201 gest that greater than 1:2 ratio transfusion in the setting of massive hemorrhage may not be appropri

202 In the setting of medulloblastoma, spontaneous or orthot

203 exercise on cutaneous regenerative capacity in the setting of metabolic syndrome.

204 velopment of endocrine resistance especially in the setting of metastatic disease.

205 uch testing can be challenging, particularly in the setting of metastatic disease.

206 se to therapy; this information is important in the setting of metastatic disease.

207 cipate in pathologic fibrotic reactions, or, in the setting of microbial invasion, can cooperate with

208 may constitute an efficient strategy for C3G in the setting of MIg, as rapid achievement of hematolog

209 pose metabolic dysfunction of male offspring in the setting of MO.

210 neate tumor margins of basal cell carcinomas in the setting of Mohs micrographic surgery.

211 , as many as 80%, of SCD events, which occur in the setting of more preserved left ventricular ejecti

212 ittent Head Drops have been in fact reported in the setting of movement disorders, sleep disorders an

213 In the setting of multifactorial risk reduction with sta

214 vivo and are unable to rescue hematopoiesis in the setting of myelosuppression.

215 c pathways affected by the secretome of CPCs in the setting of myocardial infarction.

216 Food-specific IgG antibodies arise in the setting of naturally resolving food allergy and a

217 so opened up a range of exciting indications in the setting of NCMLD.

218 In the setting of need for immunosuppression, additional

219 pertoire revealed expansion of T cell clones in the setting of neoantigen loss.

220 s leading to the development of lung disease in the setting of neonatal necrotizing enterocolitis (NE

221 dexamethasone has shown significant efficacy in the setting of newly diagnosed myeloma.

222 In the setting of non-penetrating TBI, sterile brain inf

223 ascularization patterns among these patients in the setting of non-ST-segment-elevation myocardial in

224 , mPAP of 35 mm Hg or greater can also occur in the setting of normal pulmonary vascular resistance f

225 and significantly reduced T-cell infiltrates in the setting of "normal-appearing" or nonlesional AD s

226 nuation of maladaptive sympathetic signaling in the setting of obesity and myocardial infarction.

227 Here, we show that, in the setting of obesity, inflammatory input through in

228 ctively increased in response to feeding and in the setting of obesity-linked insulin resistance.

229 ts have been developed for hepatic steatosis in the setting of obesity.

230 Recommendations for special populations and in the settings of opportunistic infections and concomit

231 ug sequestration in the biofilm matrix, and, in the setting of outbreaks, suboptimal infection contro

232 is sufficient to partially restore mitophagy in the setting of PARKIN knockdown, suggesting redundanc

233 Prompt escalation of care in the setting of patient deterioration can prevent furt

234 terial thrombosis, and obstetric morbidities in the setting of persistently positive levels of antiph

235 heral blood and lymphoid tissues, especially in the setting of persisting viremia.

236 sed (personalized) cancer treatment strategy in the setting of phase 1 clinical trials was analyzed.

237 rongly predict long-term mortality after PCI in the setting of PMI.

238 In the setting of polymicrobial inflammatory disease, su

239 d receptor antagonists (MRA) improve outcome in the setting of post-myocardial infarction (MI) heart

240 n important role in tumor metastasis in vivo in the setting of pre-diabetes and endogenous hyperinsul

241 animals and on established immune responses in the setting of pre-existing food allergy.

242 in translational cancer genomics studies and in the setting of precision medicine.

243 nal measures could prove particularly useful in the setting of predicting atrial fibrillation, which

244 Elevated donor troponin I levels in the setting of preserved left ventricular ejection fr

245 pon to exclude bony metastases, particularly in the setting of primary cancer with a known tendency t

246 nt of mechanisms similar to those implicated in the setting of primary hemophagocytic lymphohistiocyt

247 sis (CF) suffer worse outcomes, particularly in the setting of Pseudomonas aeruginosa infection.

248 the prostate dramatically altered phenotypes in the setting of Pten loss, with early neoplastic lesio

249 standing, diagnosis, and design of therapies in the setting of PU.

250 and is protective against neurodegeneration in the setting of pure tauopathy.

251 ticipated link between bone marrow and brain in the setting of radiation injury.

252 r of cetuximab response and altered immunity in the setting of radiotherapy and cisplatin treatment a

253 universal approach to ensuring blood safety in the setting of rapidly emerging infectious diseases i

254 atient outcomes for robotic compared to LLAR in the setting of rectal cancer.

255 To evaluate HRCM's diagnostic accuracy in the setting of recurrent or persistent EMPD as well a

256 ts that trigger spontaneous firing of muscle in the setting of reduced ClC-1 current.

257 NOACs include dose adjustment of the agents in the setting of renal dysfunction and avoidance of the

258 with age and is higher in persistent AF and in the setting of repeat AF ablation.

259 ne offers greatest potential for protection, in the setting of repeated occupational Mtb exposure.

260 normal parenchymal findings on chest imaging in the setting of respiratory signs and/or symptoms.

261 ntify patients at high risk of developing HF in the setting of right ventricular pacing and to determ

262 d care in an effort to drive better outcomes in the setting of rising health care costs.

263 circulation, a finding that is recapitulated in the setting of scleroderma-related interstitial lung

264 sary for mediating proinflammatory responses in the setting of sepsis.

265 role in regulating inflammation and survival in the setting of septic insult by targeting MyD88- and

266 vasodilators as well as vascular compliance in the setting of severe HF.

267 nd ameliorated myocardial reperfusion injury in the setting of severe hypertension.

268 on or PR who are anatomically suitable, even in the setting of significant concomitant TR.

269 However, in the setting of significant intratumoral heterogeneity

270 In the setting of solid-organ transplantation, calcineur

271 able to assess the coronary microcirculation in the setting of ST-segment-elevation myocardial infarc

272 th only a modest increase in treatment times in the setting of ST-segment-elevation myocardial infarc

273 a poor prognosis in patients undergoing PCI in the setting of stable coronary artery disease or acut

274 rinsic programs that ameliorate organ damage in the setting of sterile immunopathology.

275 e a potent thrombolytic activity of ADAMTS13 in the setting of stroke, which might become useful in t

276 hrombolytic effect in VWF-containing thrombi in the setting of stroke.

277 ophysiology, mechanism, and management of VT in the setting of structural heart disease and discuss t

278 Management of hemolysis in the setting of suspected device thrombosis in continu

279 vasoactive protein endothelin-1 (ET-1) occur in the setting of systemic inflammatory response syndrom

280 known risk of cutaneous surgical procedures in the setting of systemic isotretinoin therapy.

281 and fully ablative laser are not recommended in the setting of systemic isotretinoin treatment.

282 fining inclusion criteria of clinical trials in the settings of T1D.

283 1021 to incident CVD morbidity and mortality in the setting of T2D.

284 in children and how early initiation of cART in the setting of the developing infant immune system li

285 s-sectional, multicenter observational study in the setting of the HCMNet network of HCM clinical cen

286 biota in immune development and function and in the setting of the threshold for immune responses tha

287 e findings suggest that active CMV infection in the setting of treated HIV may represent an attractiv

288 vulvovaginal candidiasis (VVC), particularly in the setting of treatment failure and recurrence.

289 ggest that when glucagon activity is blocked in the setting of type 1 diabetes, the plasma ghrelin le

290 individuals but currently cannot be induced in the setting of vaccination.

291 er after 1 cycle of NAC weakly predicted pCR in the setting of variable NAC regimens.

292 CRT) is a potent treatment for heart failure in the setting of ventricular dyssynchrony.

293 We employed this optical system in the setting of ventricular tachycardia to optimize me

294 In the setting of viral hepatitis, increased expression

295 ting this benefit have been mostly performed in the setting of viral hepatitis, particularly hepatiti

296 rious, non-AIDS-defining comorbidities, even in the setting of viral suppression with combination ant

297 In this study, we asked about pDC behavior in the setting of virus-free inflammation.

298 The pharmacokinetics of cyclosporine in the setting of vismodegib administration and weekly m

299 ting body composition and laboratory results in the setting of volume overload and liver dysfunction.

300 patients with CHD should only be considered in the setting of well-designed clinical trials.